Antiangiogenic immunotherapy suppresses desmoplastic and chemoresistant intestinal tumors in mice
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antiangiogenic immunotherapy suppresses desmoplastic and chemoresistant intestinal tumors in mice
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume -, Issue -, Pages -
Publisher
American Society for Clinical Investigation
Online
2020-02-04
DOI
10.1172/jci129558
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Coordination of Immune-Stroma Crosstalk by IL-6 Family Cytokines
- (2019) Nathaniel R. West Frontiers in Immunology
- Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis
- (2019) Rene Jackstadt et al. CANCER CELL
- The Immune Revolution: A Case for Priming, Not Checkpoint
- (2018) Robert H. Vonderheide CANCER CELL
- Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity
- (2018) Victor H. Engelhard et al. JOURNAL OF IMMUNOLOGY
- TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
- (2018) Daniele V. F. Tauriello et al. NATURE
- Genomics and emerging biomarkers for immunotherapy of colorectal cancer
- (2018) Jakob Nikolas Kather et al. SEMINARS IN CANCER BIOLOGY
- PROX1 is a transcriptional regulator of MMP14
- (2018) Silvia Gramolelli et al. Scientific Reports
- Intratumoral stromal morphometry predicts disease recurrence but not response to 5-fluorouracil-results from the QUASAR trial of colorectal cancer
- (2017) Gordon G A Hutchins et al. HISTOPATHOLOGY
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade
- (2017) Martina Schmittnaegel et al. Science Translational Medicine
- Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
- (2017) Elizabeth Allen et al. Science Translational Medicine
- Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification
- (2017) Philip D. Dunne et al. Nature Communications
- Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer
- (2017) Claudio Isella et al. Nature Communications
- A Blueprint to Advance Colorectal Cancer Immunotherapies
- (2017) Dung T. Le et al. Cancer Immunology Research
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- (2016) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
- (2016) Bernhard Mlecnik et al. IMMUNITY
- Designer matrices for intestinal stem cell and organoid culture
- (2016) Nikolce Gjorevski et al. NATURE
- IFN and CCL2 Cooperate to Redirect Tumor-Infiltrating Monocytes to Degrade Fibrosis and Enhance Chemotherapy Efficacy in Pancreatic Carcinoma
- (2016) K. B. Long et al. Cancer Discovery
- The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells
- (2016) Gabriele Romano et al. Oncotarget
- CD40 Stimulation Obviates Innate Sensors and Drives T Cell Immunity in Cancer
- (2016) Katelyn T. Byrne et al. Cell Reports
- Haemopedia: An Expression Atlas of Murine Hematopoietic Cells
- (2016) Carolyn A. de Graaf et al. Stem Cell Reports
- Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancer
- (2016) Eleonora Timperi et al. OncoImmunology
- Targeting the tumor vasculature to enhance T cell activity
- (2015) Evripidis Lanitis et al. CURRENT OPINION IN IMMUNOLOGY
- Blockade of MMP14 Activity in Murine Breast Carcinomas: Implications for Macrophages, Vessels, and Radiotherapy
- (2015) Eleanor I. Ager et al. JNCI-Journal of the National Cancer Institute
- Stromal gene expression defines poor-prognosis subtypes in colorectal cancer
- (2015) Alexandre Calon et al. NATURE GENETICS
- Stromal contribution to the colorectal cancer transcriptome
- (2015) Claudio Isella et al. NATURE GENETICS
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity
- (2015) J. David Peske et al. Nature Communications
- Blockade of MMP14 Activity in Murine Breast Carcinomas: Implications for Macrophages, Vessels, and Radiotherapy
- (2015) Eleanor I. Ager et al. JNCI-Journal of the National Cancer Institute
- CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis
- (2014) Matilde Todaro et al. Cell Stem Cell
- Prox1 ablation in hepatic progenitors causes defective hepatocyte specification and increases biliary cell commitment
- (2014) A. Seth et al. DEVELOPMENT
- Fibroblast heterogeneity in the cancer wound
- (2014) Daniel Öhlund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Prox1 Promotes Expansion of the Colorectal Cancer Stem Cell Population to Fuel Tumor Growth and Ischemia Resistance
- (2014) Zoltán Wiener et al. Cell Reports
- PROX1 Promotes Metabolic Adaptation and Fuels Outgrowth of Wnt high Metastatic Colon Cancer Cells
- (2014) Simone Ragusa et al. Cell Reports
- Ang-2-VEGF-A CrossMab, a Novel Bispecific Human IgG1 Antibody Blocking VEGF-A and Ang-2 Functions Simultaneously, Mediates Potent Antitumor, Antiangiogenic, and Antimetastatic Efficacy
- (2013) Y. Kienast et al. CLINICAL CANCER RESEARCH
- Agonistic CD40 Antibodies and Cancer Therapy
- (2013) R. H. Vonderheide et al. CLINICAL CANCER RESEARCH
- Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition
- (2013) Paul Roepman et al. INTERNATIONAL JOURNAL OF CANCER
- Colorectal cancer
- (2013) Hermann Brenner et al. LANCET
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
- (2013) Laetitia Marisa et al. PLOS MEDICINE
- Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis Initiation
- (2012) Alexandre Calon et al. CANCER CELL
- The extracellular matrix: A dynamic niche in cancer progression
- (2012) Pengfei Lu et al. JOURNAL OF CELL BIOLOGY
- Notch1 counteracts WNT/β-catenin signaling through chromatin modification in colorectal cancer
- (2012) Hyun-A Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Expression and prognostic value of transcription factor PROX1 in colorectal cancer
- (2011) M Skog et al. BRITISH JOURNAL OF CANCER
- Local Activation of CD8 T Cells and Systemic Tumor Eradication without Toxicity via Slow Release and Local Delivery of Agonistic CD40 Antibody
- (2011) M. F. Fransen et al. CLINICAL CANCER RESEARCH
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- A phase I study of dacetuzumab (SGN-40, a humanized anti-CD40 monoclonal antibody) in patients with chronic lymphocytic leukemia
- (2010) Richard R. Furman et al. LEUKEMIA & LYMPHOMA
- Prox1 Is Required for Granule Cell Maturation and Intermediate Progenitor Maintenance During Brain Neurogenesis
- (2010) Alfonso Lavado et al. PLOS BIOLOGY
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- (2009) David A. Barbie et al. NATURE
- Transcription Factor PROX1 Induces Colon Cancer Progression by Promoting the Transition from Benign to Highly Dysplastic Phenotype
- (2008) Tatiana V. Petrova et al. CANCER CELL
- Prox1 maintains muscle structure and growth in the developing heart
- (2008) C. A. Risebro et al. DEVELOPMENT
- Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity
- (2008) N. C. Johnson et al. GENES & DEVELOPMENT
- Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer
- (2008) Paul Salama et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search